Yocca Frank

Average Profitability
91.88%
Insider Buys Quantity
5
Insider Buys Sum
$132,596.19
Insider Sells Quantity
10
Insider Sells Sum
$6.16M

Insider Activity of Yocca Frank

According to the SEC Form 4 filings, Yocca Frank, being in a position of

  1. Chief Scientific Officer at BioXcel Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 9399 shares for $7,630,
    over all time since 2018-11-29, has bought 16794 shares for $132,596, and sold 150384 shares for $6.16M.

The largest purchase of all time was on 2019-08-13 and amounted to 13094 shares of BioXcel Therapeutics, Inc. for $113,525.

The largest sale of all time was on 2021-02-16 and amounted to 30000 shares of BioXcel Therapeutics, Inc. for $1.73M.

Biography of Yocca Frank

No biography is available at this moment.

2024-12-16SaleBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
430
0.0008%
$0.35$152-14.76%
2024-10-03SaleBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
7,175
0.0181%
$0.55$3,946-1.4%
2024-09-16SaleBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
355
0.0009%
$0.69$245-13.25%
2024-06-17SaleBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
372
0.0009%
$1.28$476-53.95%
2024-04-04SaleBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
1,067
0.0031%
$2.63$2,812-73.24%
2023-03-15SaleBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
985
0.0035%
$19.69$19,396-79.74%
2023-01-20SaleBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
50,000
0.173%
$30.00$1.5M-66.53%
2021-03-15SaleBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
30,000
0.1218%
$48.50$1.46M-42.15%
2021-02-16SaleBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
30,000
0.1249%
$57.68$1.73M-47.15%
2021-01-25SaleBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
30,000
0.1187%
$48.39$1.45M-38.48%
2019-08-13PurchaseBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
13,094
0.0818%
$8.67$113,525+108.29%
2018-12-04PurchaseBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
900
0.0066%
$5.20$4,678+88.27%
2018-12-03PurchaseBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
900
0.0063%
$5.21$4,692+79.76%
2018-11-30PurchaseBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
900
0.0066%
$5.20$4,679+89.65%
2018-11-29PurchaseBioXcel Therapeutics, Inc.
BTAI
Chief Scientific Officer
1,000
0.0073%
$5.02$5,022+93.45%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.